19/12/2018 |
NeuroVive Pharmaceutical AB |
Magnus Hansson |
Chief Medical Officer |
|
Acquisition |
NeuroVive Pharmaceutical AB |
Share |
SE0002575340 |
19/12/2018 |
20,000 |
Quantity |
1.31 |
SEK |
|
Notification
|
06/05/2018 |
NeuroVive Pharmaceutical AB |
David Olof Rikard Bejker |
Styrelseledamot/suppleant |
|
Subscription |
NeuroVive Pharmaceutical BTU |
|
SE0011089002 |
27/04/2018 |
3,819 |
Quantity |
8.00 |
SEK |
|
Notification
|
25/04/2018 |
NeuroVive Pharmaceutical AB |
Erik Kinnman |
VD |
|
Subscription |
NeuroVive Pharmaceutical AB BTU |
|
SE0008241871 |
25/04/2018 |
8,812 |
Quantity |
8.00 |
SEK |
History |
Notification
|
25/04/2018 |
NeuroVive Pharmaceutical AB |
Erik Kinnman |
VD |
|
Acquisition |
NeuroVive Pharmaceutical AB BTU |
|
SE0008241871 |
25/04/2018 |
8,812 |
Quantity |
8.00 |
SEK |
Revised |
Notification
|
25/04/2018 |
NeuroVive Pharmaceutical AB |
Marcus Keep, Eskil Elmée and Michael Vickers |
Board Member, CSO and Chair Nomination in NeuroVive |
Yes |
Disposal |
Rights Issue Warrants |
|
|
20/04/2018 |
11,623,296 |
Quantity |
0.01 |
SEK |
History |
Notification
|
25/04/2018 |
NeuroVive Pharmaceutical AB |
Marcus Keep, Eskil Elmée and Michael Vickers |
Board Member, CSO and Chair Nomination in NeuroVive |
Yes |
Disposal |
Rights Issue Warrants |
|
|
20/04/2018 |
11,623,296 |
Quantity |
0.11 |
SEK |
Revised |
Notification
|
25/04/2018 |
NeuroVive Pharmaceutical AB |
Eskil Elmér |
Forskningschef |
|
Subscription |
NeuroVive Pharmaceutical BTU |
|
SE0011089002 |
24/04/2018 |
19,407 |
Quantity |
8.00 |
SEK |
|
Notification
|
25/04/2018 |
NeuroVive Pharmaceutical AB |
Magnus Hansson |
Chief Medical Officer |
|
Allotment |
NeuroVive Pharmaceutical AB BTU |
|
SE0011089002 |
24/04/2018 |
20,000 |
Quantity |
8.00 |
SEK |
|
Notification
|
25/04/2018 |
NeuroVive Pharmaceutical AB |
Eskil Elmér |
Forskningschef |
|
Disposal |
NeuroVive Pharmaceutical UR |
|
SE0011088996 |
20/04/2018 |
1,060,905 |
Quantity |
0.01 |
SEK |
|
Notification
|
23/02/2017 |
NeuroVive Pharmaceutical AB |
ERIK KINNMAN |
VD |
|
Acquisition |
NeuroVive Pharmaceutical AB |
|
SE0002575340 |
23/02/2017 |
8,600 |
Quantity |
5.62 |
SEK |
|
Notification
|